Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith A Morgan

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 12, 2013
CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cellsSvetlana Grabauskiene, Edward J Bergeron, Guoan Chen, et al.
Molecular Cancer Therapeutics|December 3, 2020
Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination-Proficient Pancreatic CancerLeslie A Parsels, Carl G Engelke, Joshua Parsels, et al.
Molecular Cancer Therapeutics|February 2, 2011
Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspasesJie Yang, Donna McEachern, Wenyan Li, et al.
Cancers|April 25, 2020
Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized MedicineLianette Rivera-Báez, Ines Lohse, Eric Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repairDongping Wei, Leslie A Parsels, David Karnak, et al.
Molecular Cancer Research : MCR|May 28, 2021
Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent MannerKailiang Zhao, Qiang Zhang, Sheryl A Flanagan, et al.
Molecular Cancer Research : MCR|November 15, 2017
PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP InhibitorsLeslie A Parsels, David Karnak, Joshua D Parsels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2014
Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancerDavid Karnak, Carl G Engelke, Leslie A Parsels, et al.
Molecular Cancer Therapeutics|January 14, 2009
Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cellsLeslie A Parsels, Meredith A Morgan, Daria M Tanska, et al.
Translational Oncology|July 21, 2020
UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancerYajing Liu, Sahezeel Awadia, Amy Delaney, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Lung Cancer (Amsterdam, Netherlands)|October 12, 2013
CHK1 levels correlate with sensitization to pemetrexed by CHK1 inhibitors in non-small cell lung cancer cellsSvetlana Grabauskiene, Edward J Bergeron, Guoan Chen, et al.
Molecular Cancer Therapeutics|December 3, 2020
Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination-Proficient Pancreatic CancerLeslie A Parsels, Carl G Engelke, Joshua Parsels, et al.
Molecular Cancer Therapeutics|February 2, 2011
Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspasesJie Yang, Donna McEachern, Wenyan Li, et al.
Cancers|April 25, 2020
Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized MedicineLianette Rivera-Báez, Ines Lohse, Eric Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Inhibition of protein phosphatase 2A radiosensitizes pancreatic cancers by modulating CDC25C/CDK1 and homologous recombination repairDongping Wei, Leslie A Parsels, David Karnak, et al.
Molecular Cancer Research : MCR|May 28, 2021
Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent MannerKailiang Zhao, Qiang Zhang, Sheryl A Flanagan, et al.
Molecular Cancer Research : MCR|November 15, 2017
PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP InhibitorsLeslie A Parsels, David Karnak, Joshua D Parsels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2014
Combined inhibition of Wee1 and PARP1/2 for radiosensitization in pancreatic cancerDavid Karnak, Carl G Engelke, Leslie A Parsels, et al.
Molecular Cancer Therapeutics|January 14, 2009
Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cellsLeslie A Parsels, Meredith A Morgan, Daria M Tanska, et al.
Translational Oncology|July 21, 2020
UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancerYajing Liu, Sahezeel Awadia, Amy Delaney, et al.
Pageof 8